Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Continuous Tobramycin in Cystic Fibrosis
NCT00634192Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tobramycin in cystic fibrosis (CF), sponsored by Novartis. Started Feb 2008; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00634192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634192.